Stock screenerAll disclosures →
EDGAR →
ONCY
Conviction 0HealthcareScan · Mon, Aug 10, 2026ONCY$0.8029+0.05%
ResistanceSupportVol 14Vol MA14 813.41K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.8029
Change+0.05%
Gap-1.56%
Rel volume0.23×
Avg volume1.02M
Avg $ vol843.03K
SMA 200.8192
SMA 500.8677
SMA 2000.9596
Price vs 50-7.46%
Price vs 200-16.33%
MA stackbearish
50/200 cross—
Supertrenddown · 0.9092
RSI (14)45
MACD hist0.00
MACD crossbull · 1d
Stoch %K / %D46 / 45
ADX (14)12
+DI / −DI21 / 21
RSI divergence—
MACD divergence—
ATR %+6.18%
ADR %5.20%
52w high1.42
52w low0.7516
From 52w high-43.46%
Above 52w low+6.83%
New 52w highNo
SqueezeOff
Bollinger width22.27%
%B0.41
Donchian pos31.67%
Donchian high0.9600
Donchian low0.7301
AVWAP (52w high)0.9957
vs AVWAP high-19.36%
AVWAP (52w low)0.7782
vs AVWAP low+3.17%
OBV trendDown
Chaikin MF (20)-0.08
Today vs 20d0.23×
Avg vol (14d)813.41K
Avg vol (20d)1.02M
Avg $ vol (20d)843.03K
Market cap95.83M
RS 3m (vs SPY)-16.53%
RS 6m (vs SPY)-18.19%
RS line new highNo
Trend template0/8
Technical rank20.5
1 week+3.60%
1 month-9.51%
3 months-9.78%
6 months-9.37%
1 year-12.26%
YTD-18.38%
P/E-3.33
P/B-18.68
P/S—
P/FCF-4.76
EPS-0.3000
Div yield—
ROE560.60%
ROA-352.40%
Debt/Eq—
Current1.38
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-26.17%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value90.34M
Revenue—
Net income-9.24M
Gross profit—
Free cash flow-20.12M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out119.35M
Employees29
ListedFri, Oct 5, 2001
Free float111.97M
Float %96.4%
Short interest7.95M
Days to cover4.2d
Short volume52.8%
Squeeze score44 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank20.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.05
Support0.7606
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ONCY
No recent disclosed trades by Congress in ONCY. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ONCY · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Glover Stephen C. Director · Stock Option · 2026-06-01 | Grant | 96K | $0 | 2026-06-01 | 2026-06-03 |
Holtham Angela Director · Stock Option · 2026-06-01 | Grant | 30K | $0 | 2026-06-01 | 2026-06-03 |
McAdory John Bearden Chief Operating Officer · Stock Option · 2026-06-01 | Grant | 145K | $0 | 2026-06-01 | 2026-06-03 |
Hagerman Allison Chief Technology Officer · Stock Option · 2026-06-01 | Grant | 260K | $0 | 2026-06-01 | 2026-06-03 |
Seizinger Bernd R. Director · Stock Option · 2026-06-01 | Grant | 30K | $0 | 2026-06-01 | 2026-06-03 |
Look Kirk Chief Financial Officer · Stock Option · 2026-06-01 | Grant | 260K | $0 | 2026-06-01 | 2026-06-03 |
Pisano Wayne Director · Stock Option · 2026-06-01 | Grant | 30K | $0 | 2026-06-01 | 2026-06-03 |
Kelly Jared Chief Executive Officer · Stock Option · 2026-06-01 | Grant | 755K | $0 | 2026-06-01 | 2026-06-03 |
RIGBY JONATHAN Director · Stock Option · 2026-06-01 | Grant | 30K | $0 | 2026-06-01 | 2026-06-03 |
Brown Deborah Margaret Director · Stock Option · 2026-06-01 | Grant | 30K | $0 | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in ONCY · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.